Portal de investigación
ESTUDIO DOBLE CIEGO, ALEATORIO, CONTROLADO POR PLACEBO, DE FASE II, QUE COMPARA DIFERENTES DOSIS DE GRÁNULOS DE RHUDEX CON PLACEBO EN EL TRATAMIENTO DE LA COLANGITIS BILIAR PRIMARIA.
Datos básicos
- Protocolo:
- RDG-1/PBC
- EUDRACT:
- 2020-001961-34
- NCT:
- Centro:
- HOSPITAL UNIVERSITARI I POLITÈCNIC LA FE
- Año de incio:
- 2021
- Año de finalización:
- 2023
Documentos
- No hay documentos
Participantes
Grupos
Financiadores - Promotores
Resultados del Ensayo Clínico
A Century of Progress on Wilson Disease and the Enduring Challenges of Genetics, Diagnosis, and Treatment.
Penning, Louis C.; (...); Weiskirchen, Ralf
Article. 10.3390/biomedicines11020420. 2023
A multicriteria decision analysis (MCDA) applied to three long-term prophylactic treatments for hereditary angioedema in Spain
Zozaya, Neboa; (...); Hidalgo-Vega, Alvaro
Article. 10.33393/grhta.2022.2333. 2022
A multi-criteria decision analysis on the value of nintedanib for interstitial lung diseases.
Zozaya, Neboa; (...); Verde, Luis
Article. 10.1017/S0266462322000459. 2022
Access to liver transplant for women in Spain: a national registry analysis
Tejedor Bravo, Marta; (...); Berenguer, Marina
Meeting Abstract. 2023
Addressing the Burden and Management Strategies for Disparities and Inequities Among Liver Transplant Professionals: The ILTS Experience.
Andacoglu, Oya; (...); Selzner, Nazia
Article. 10.3389/ti.2023.11240. 2023
Analysis of chemical contamination by hazardous drugs with BD HD Check(R) system in a tertiary hospital
Valero García S; (...); Poveda Andrés JL
Article. 10.1177/10781552211038518. 2021
Are MELD and MELDNa Still Reliable Tools to Predict Mortality on the Liver Transplant Waiting List?
Tejedor, Marta, Selzner, Nazia, Berenguer, Marina
Article. 10.1097/TP.0000000000004163. 2022
Automated Whole-Liver MRI Segmentation to Assess Steatosis and Iron Quantification in Chronic Liver Disease.
Martí-Aguado D; (...); Martí-Bonmatí L
Article. 10.1148/radiol.2021211027. 2022
Baricitinib against severe COVID-19: effectiveness and safety in hospitalised pretreated patients.
Iglesias Gómez R; (...); Poveda Andrés JL
Article. 10.1136/ejhpharm-2021-002741. 2021
Bioavailability of once-daily tacrolimus formulations used in clinical practice in the management of De Novo kidney transplant recipients: the better study.
Fernandez Rivera C; (...); Hernandez D
Article. 10.1111/ctr.14550. 2022
Budesonide as first-line treatment in patients with autoimmune hepatitis seems inferior to standard predniso(lo)ne administration.
Diaz-Gonzalez, Alvaro; (...); Londoño MC
Article. 10.1097/HEP.0000000000000018. 2023
CA125: a new biomarker in patients with Fontan circulation.
Fuentes, Francisco Buendia; (...); Soriano, Joaquin Rueda
Article. 10.1016/j.rec.2022.05.029. 2022
Can endothelial biomarkers before liver transplantation together with classical cardiovasculat risk factors be useful to predict cardiovascular risk after liver transplantation
Herreras Lopez, Julia; (...); Aguilera Sancho, Victoria
Meeting Abstract. 2022
Can endothelial biomarkers before LT together with classical cardiovascular risk factors be useful to predict cardiovascular risk after LT?
Herreras, J.; (...); Aguilera, V.
Article. 2022
Circulating MicroRNAs: Dynamic Markers of Liver Transplant Injury.
Mas VR, Bardhi E, Berenguer M
Article. 10.1097/TP.0000000000003816. 2021
Cirrhosis is associated with lower serological responses to COVID-19 vaccines in patients with chronic liver disease.
Simao, Andre Lopes; (...); Castro, Rui E
Article. 10.1016/j.jhepr.2023.100697. 2023
Clinical benefits of a Bayesian model for plasma-derived factor VIII/VWF after one year of pharmacokinetic-guided prophylaxis in severe/moderate hemophilia A patients
Megias-Vericat, JE; (...); Poveda, JL
Article. 10.1016/j.thromres.2021.07.009. 2021
CMV reactivation after liver transplantation (LT) in HIV infected is similar to non-HIV patients: a single center comparative study
Garcia-Garcia, Sonia; (...); Aguilera Sancho, Victoria
Meeting Abstract. 2023
CMV reactivation is associated with lower hepatocellular carcinoma (HCC) recurrence after liver transplantation (LT)
Aguilera Sancho, Victoria; (...); Berenguer, Marina
Meeting Abstract. 2022
Costs of the management of hemophilia A with inhibitors in Spain
Bonanad, S; (...); Gonzalez-Dominguez, A
Article. 10.33393/grhta.2021.2234. 2021
COVID vaccination among liver transplant recipients: A EASL-ESOT/ELITA-ILTS multi society survey
Vinaixa, Carmen; (...); Berenguer, Marina
Meeting Abstract. 2022
COVID vaccination among liver transplant recipients: an EASL-ESOT/ELITA-ILTS multi-society international survey
Vinaixa, C.; (...); Berenguer, M.
Meeting Abstract. 2022
Cumulative exposure to tacrolimus and incidence of cancer after liver transplantation
Rodriguez-Peralvarez, Manuel; (...); Gomez Bravo, Miguel Angel
Meeting Abstract. 2022
Cumulative exposure to tacrolimus and incidence of cancer after liver transplantation.
Rodríguez-Perálvarez M; (...); Bernal-Bellido C
Article. 10.1111/ajt.17021. 2022
Cytomegalovirus reactivation is associated with lower hepatocelullar carcinoma recurrence rates after liver transplantation
Aguilera Sancho, Victoria; (...); Rodriguez-Peralvarez, Manuel
Meeting Abstract. 2023
CYTOMEGALOVIRUS SPECIFIC POLYFUNCTIONAL T-CELL RESPONSES EXPRESSING CD107A ASSOCIATED WITH CONTROL OF CMV REACTIVATION AFTER LIVER TRANSPLANTATION
Carvalho-Gomes, A; (...); Aguilera, V
Meeting Abstract. 2021
Cytomegalovirus specific polyfunctional T-cell responses expressing CD107a predict control of CMV infection after liver transplantation.
Carvalho-Gomes Â; (...); López-Labrador FX
Article. 10.1016/j.cellimm.2021.104455. 2022
Cytomegalovirus specific polyfunctional T-cells control CMV reactivation after liver transplantation
Carvalho-Gomes, A; (...); Aguilera, V
Meeting Abstract. 2021
Characteristics and impact of sex in a cohort of patients with primary sclerosing cholangitis: Experience of a transplant center in the Mediterranean basin.
Mínguez Sabater A; (...); Berenguer, Marina
Article. 10.1016/j.gastrohep.2021.03.017. 2022
CHARACTERISTICS AND IMPACT OF SEX IN PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS: A MULTICENTER STUDY FROM A CLASSICALLY LOW PREVALENCE AREA
Minguez, Alejandro; (...); Berenguer, Marina
Meeting Abstract. 2021
Characteristics and trends of liver transplantation in a cohort of patients with primary sclerosing cholangitis: a retrospective multicenter study
Minguez, A.; (...); Berenguer, M.
Meeting Abstract. 2022
Characteristics, trends and outcomes of liver transplantation (LT) for primary sclerosing cholangitis (PSC) in female patients: analysis of the European Liver Transplantation Registry (ELTR)
Di Maira, T; (...); European Liver & Intestine
Meeting Abstract. 2021
Characteristics, Trends, and Outcomes of Liver Transplantation for Primary Sclerosing Cholangitis in Female Versus Male Patients: An Analysis From the European Liver Transplant Registry
Berenguer M; (...); European Liver Intestine Transplan
Article. 10.1097/TP.0000000000003542. 2021
Design and rationale for a real-world prospective, multicenter registry of myocardial revascularization failure and secondary revascularization: The REVASEC study.
Salinas P; (...); Escaned J
Article. 10.1016/j.carrev.2021.11.015. 2021
Digital Pathology Enables Automated and Quantitative Assessment of Inflammatory Activity in Patients with Chronic Liver Disease.
Marti-Aguado, David; (...); Marti-Bonmati, Luis
Article. 10.3390/biom11121808. 2021
Early liver transplantation for acute alcoholic hepatitis In a spanish liver transplant center
Aguilera Sancho, Victoria; (...); Berenguer, Marina
Meeting Abstract. 2023
Early predictors of corticosteroid response in acute severe autoimmune hepatitis: A nationwide multicenter study
Tellez, Luis; (...); Albillos, Agustin
Article. 10.1111/apt.16926. 2022
Economic Impact of European Liver and Intestine Transplantation Association (ELITA) Recommendations for Hepatitis B Prophylaxis After Liver Transplantation.
Cortesi, Paolo Angelo; (...); Belli, Luca Saverio
Article. 10.3389/ti.2023.10954. 2023
Effectiveness of Caplacizumab Nanobody in Acquired Thrombotic Thrombocytopenic Purpura Refractory to Conventional Treatment
Palanques-Pastor T; (...); Poveda Andrés JL
Article. 10.1159/000517813. 2021
EFFICACY AND SAFETY OF BUDESONIDE AS FIRST LINE TREATMENT IN PATIENTS WITH AUTOIMMUNE HEPATITIS: SPANISH MULTICENTER STUDY
Diaz-Gonzalez, Alvaro; (...); Carlota Londono, Maria
Meeting Abstract. 2021
EFFICACY OF OBETICHOLIC ACID (OCA) VS PLACEBO AND EXTERNAL CONTROL (EC) ON CLINICAL OUTCOMES IN PRIMARY BILIARY CHOLANGITIS (PBC)
Kowdley, Kris V.; (...); Villamil, Alejandra
Meeting Abstract. 2023
Enhanced recovery after surgery programs improve short-term outcomes after liver transplantation-A systematic review and meta-analysis
Tinguely, Pascale; (...); Spiro, Michael
Article. 10.1111/ctr.14453. 2021
Enhanced recovery for liver transplantation: recommendations from the 2022 International Liver Transplantation Society consensus conference.
Pollok, Joerg M.; (...); Spiro, Michael
Article. 10.1016/S2468-1253(22)00268-0. 2023
Ertapenem neurotoxicity in liver transplantation.
Martinez Delgado, Sara; (...); Conde, Isabel
Article. 10.17235/reed.2021.8469/2021. 2022
ESOT Consensus Platform for Organ Transplantation: Setting the Stage for a Rigorous, Regularly Updated Development Process.
Cillo U; (...); Selzner N
Review. 10.3389/ti.2022.10915. 2022
EXPERT CONSENSUS CRITERIA AND PRACTICAL RECOMMENDATIONS FOR PBC CARE IN THE COVID-19 ERA AND BEYOND
Berenguer, Marina; (...); Carbone, Marco
Meeting Abstract. 2021
Expert consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology on the determination of biomarkers in pancreatic and biliary tract cancer
Vera, Ruth; (...); Madrigal-Rubiales, Beatriz
Article. 10.1007/s12094-022-02873-0. 2022
Expert consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology on the determination of biomarkers in pancreatic and biliary tract cancer.
Vera, Ruth; (...); Madrigal-Rubiales, Beatriz
Article. 10.1016/j.patol.2022.06.004. 2023
Exploring pregnancy, breastfeeding and contraception among women with Wilson disease in Spain: results from the Spanish Wilson registry
Romero-Gutierrez, Marta; (...); Marino, Zoe
Meeting Abstract. 2023
External validation of models to predict hepatocellular carcinoma (HCC) in HCV SVR F3-F4 patients
Sahuco, Ivan; (...); Berenguer, Marina
Meeting Abstract. 2023
Fetal exposure to tofacitinib during the first trimester: A healthy newborn case report
Fernandez-Sanchez, M; (...); Poveda-Andres, JL
Article. 10.1002/bdr2.1942. 2021
First nationwide genetic study on Wilson disease (Spanish Wilson registry): high diversity in mutations and in use of genetic evaluation, association with clinical data and influence on diagnosis and health costs
Alonso Castellano, Pablo; (...); Garcia-Villarreal, Luis
Meeting Abstract. 2023
Frailty and Sarcopenia in Acute-on-Chronic Liver Failure
Renau, LP; (...); Berenguer M
Article. 10.1002/hep4.1722. 2021
GENDER AND RACIAL DISCRIMINATION AMONG LIVER TRANSPLANTATION PROFESSIONALS: A SURVEY FROM ILTS EDI COMMITTEE
Andacoglu, Oya; (...); Selzner, Nazia
Meeting Abstract. 2021
Gender and racial discrimination among liver transplantation professionals: report of a global survey
Aguilera, V.; (...); Selzner, N.
Article. 2022
Gender and Racial Disparity Among Liver Transplantation Professionals: Report of a Global Survey
Aguilera, Victoria; (...); Selzner, Nazia
Article. 10.3389/ti.2022.10506. 2022
Gender differences in liver transplantation (LT) for acute liver failure (ALF) in a multicentre ALF-LT Spanish cohort
Conde, Isabel; (...); Aguilera Sancho, Victoria
Meeting Abstract. 2023
Global impact of the first wave of COVID-19 on liver transplant centers: A multi-society survey (EASL-ESOT/ELITA-ILTS).
Russo FP; (...); Polak WG
Article. 10.1016/j.jhep.2021.09.041. 2021
Good posttransplant outcome using donors after cardiac death (DCD) when applying strict selection criteria
de la Varga, MF; (...); Castillo, MP
Meeting Abstract. 2021
Good post-transplant outcomes using liver donors after circulatory death when applying strict selection criteria: A propensity-score matched-cohort study.
Fernandez-de la Varga, Margarita; (...); Aguilera, Victoria
Article. 10.1016/j.aohep.2022.100724. 2022
Guide to Good Humanization Practices in Patients with Rare Diseases. who vadis
Editorial Material. 2022
Healthcare Resource Utilization among Patients between 60-75 Years with Secondary Acute Myeloid Leukemia Receiving Intensive Chemotherapy Induction: A Spanish Retrospective Observational Study
Solana-Altabella, Antonio; (...); Martinez-Cuadron, David
Article. 10.3390/cancers14081921. 2022
Hepatic nerve endings are rewired by cholestatic injury to connect inflamed lymphatics to sites of ductular remodelling
Noon, Luke; (...); Lloyd, Alison
Meeting Abstract. 2023
Hepatic steatosis and steatohepatitis: a functional meta-analysis of sex-based differences in transcriptomic studies
Catala-Senent, Jose F.; (...); Garcia-Garcia, Francisco
Article. 10.1186/s13293-021-00368-1. 2021
High incidence of pulmonary thromboembolism in hospitalized SARS-CoV-2 infected patients despite thrombo-prophylaxis.
El-Qutob D; (...); Carrera-Hueso FJ
Article. 10.1016/j.hrtlng.2022.02.003. 2022
Hospital pharmacy initiatives for improving the management of patients with congenital coagulopathies
Bruno Montoro-Ronsano, Jose; (...); Alberto Vella, Vincenzo
Article. 10.7399/fh.11729. 2022
Hospitalization budget impact during the COVID-19 pandemic in Spain.
Carrera-Hueso, F. J.; (...); Crespo-Palomo, C.
Article. 10.1186/s13561-021-00340-0. 2021
How can artificial intelligence optimize value-based contracting?
Poveda, Jose Luis; (...); Medrano, Ignacio H.
Letter. 10.1186/s40545-022-00475-3. 2022
Impact of COVID-19 on the liver and on the care of patients with chronic liver disease, hepatobiliary cancer, and liver transplantation: an updated EASL position paper.
Marjot, Thomas; (...); Cornberg, Markus
Article. 10.1016/j.jhep.2022.07.008. 2022
Impact of muscle mass on survival of patients with hepatocellular carcinoma after liver transplantation beyond the Milan criteria
Beumer, Berend R.; (...); IJzermans, Jan N. M.
Article. 10.1002/jcsm.13053. 2022
Impact of muscle mass on survival of patients with hepatocellular carcinoma after liver transplantation beyond the Milan criteria
Beumer, Berend; (...); Ijzermans, Jan
Meeting Abstract. 10.1002/jcsm.13053. 2022
Impact of suffering Wilson disease in Spain: an observational cross-sectional multicenter study
Marino, Zoe; (...); Anguera, Anna
Meeting Abstract. 2023
Inadequate social support decreases survival in decompensated liver cirrhosis patients.
García Morales N; (...); Cubiella, Joaquin
Article. 10.1016/j.gastrohep.2022.04.006. 2022
Incidence and prognostic impact of cancer after liver transplantation
Gastaca, M; (...); Rodriguez-Peralvarez, M
Meeting Abstract. 2021
Incidence of de novo tumors after liver transplantation (LT) in HIV infected is similar to non-HIV patients: a single center comparative study
Chafer, Isabel Terol; (...); Sancho, Victoria Aguilera
Meeting Abstract. 2023
International Liver Transplantation Society Global Census report: a first look at the pediatric liver transplantation activity around the world
Lopez-Verdugo, F; (...); Pediat Liver Transplantation
Meeting Abstract. 2021
LATTICE radiotherapy: A one institution experience
Solero, I.; (...); Conde, A.
Meeting Abstract. 2023
Lessons from population genomics for Wilson disease: Prevalence, penetrance of mutations, clinical implications and design of regional screening programmes
Alonso Castellano, Pablo; (...); Garcia-Villarreal, Luis
Meeting Abstract. 2023
Liver transplant for porto-sinusoidal vascular disease (psvd): long-term outcome
Magaz, M; (...); Valdig
Meeting Abstract. 2021
Liver Transplantation 2023: Status Report, Current and Future Challenges.
Terrault, Norah A; (...); Heimbach, Julie
Article. 10.1016/j.cgh.2023.04.005. 2023
LIVER TRANSPLANTATION FOR NON-ALCOHOLIC STEATOHEPATITIS: LOW PREVALENCE REGIONS ARE CATCHING UP
Martinez Arenas, Laura; (...); Berenguer, Marina
Meeting Abstract. 2022
Liver transplantation for patients with acute-on-chronic liver failure (ACLF) in Europe: Results of the ELITA/EF-CLIF collaborative study (ECLIS)
Belli, LS; (...); ELITA EF-CLIF Working Grp
Article. 10.1016/j.jhep.2021.03.030. 2021
Liver Transplantation for Porto-Sinusoidal Vascular Liver Disorder: Long-term Outcome.
Magaz, Marta; (...); Garcia-Pagan, Juan Carlos
Article. 10.1097/TP.0000000000004444. 2022
LOCATION AND ALLOCATION: INEQUITY OF ACCESS TO LIVER TRANSPLANTATION FOR PATIENTS WITH ACUTE-ON-CHRONIC LIVER FAILURE GRADE 3 (ACLF-3) ACROSS EUROPE.
Artzner, Thierry; (...); Jalan, Rajiv
Meeting Abstract. 2021
Location and allocation: inequity of access to liver transplantation for patients with severe acute-on-chronic liver failure in Europe.
Artzner, Thierry; (...); Jalan, Rajiv
Article. 10.1002/lt.26499. 2022
Long-term outcome after living donor liver transplantation compared to donation after brain death in autoimmune liver diseases: Experience from the European Liver Transplant Registry.
Heinemann M; (...); all the other contributing centers (www.eltr.org) and the European Liver and Int
Article. 10.1111/ajt.16864. 2022
Long-term prospective follow-up of a primary biliary cholangitis (PBC) multicenter cohort treated with Obeticholic Acid (OCA). Interaction effect of triple therapy with fibrates
Gomez-Dominguez, Elena; (...); Fernandez-Rodriguez, Conrado
Meeting Abstract. 2023
Long-term survival after living donor liver transplantation in primary sclerosing cholangitis
Liwinski, T; (...); Schramm, C
Meeting Abstract. 2021
MAGNETIC RESONANCE IMAGING-BASED BIOMARKER ACCURATELY IDENTIFIES PATIENTS WITH NONALCOHOLIC STEATOHEPATITIS AND CLINICALLY SIGNIFICANT LIVER FIBROSIS: A MULTICENTER, INTERNATIONAL, VALIDATION STUDY
Arnouk, Joud; (...); Marti-Bonmati, Luis
Meeting Abstract. 2021
Magnetic resonance imaging-based biomarker accurately identifies patients with nonalcoholic steatohepatitis and significant liver fibrosis: a multicentre, international, validation study
Marti-Aguado, David; (...); Marti-Bonmati, Luis
Meeting Abstract. 2022
Main clinical characteristics and evolutionary events among patients suffering Wilson disease in Spain: first results from the Spanish Wilson registry
Marino, Zoe; (...); Castillo, Pilar
Meeting Abstract. 2023
Management of flexible cavovarus foot in patients with Charcot-Marie-Tooth disease: midterm results.
Megías-Vericat JE; (...); Poveda-Andrés JL
Article. 2021
Manipulación de fármacos para su administración por gastrostomía endoscópica percutánea en pacientes con esclerosis lateral amiotrófica y nutrición enteral.
Vázquez Polo A; (...); Vázquez Costa JF
Article. 10.20960/nh.03946. 2022
Matching-Adjusted Indirect Comparison of Efficacy and Consumption of rVIII-SingleChain Versus Two Recombinant FVIII Products Used for Prophylactic Treatment of Adults/Adolescents with Severe Haemophilia A
Bonanad, S; (...); Santos, S
Article. 10.1007/s12325-021-01853-0. 2021
Metabolic Phenotyping in Prostate Cancer Using Multi-Omics Approaches.
Gomez-Cebrian, Nuria; (...); Puchades-Carrasco, Leonor
Article. 10.3390/cancers14030596. 2022
Metabolic syndrome before liver transplantation: does it have an impact on post liver transplantation outcomes?
Herreras Lopez, Julia; (...); Aguilera, Victoria
Article. 10.17235/reed.2022.8384/2021. 2022
Metabolomic analysis to discriminate drug-induced liver injury (DILI) phenotypes
Quintas, G; (...); Castell, JV
Article. 10.1007/s00204-021-03114-z. 2021
Mitochondrial bioenergetics boost macrophages activation promoting liver regeneration in metabolically compromised animals.
Goikoetxea-Usandizaga, Naroa; (...); Martínez-Chantar ML
Article. 10.1002/hep.32149. 2021
Mortality and Causes of Death After Liver Transplantation: Analysis of Sex Differences in a Large Nationwide Cohort.
Serrano MT; (...); Salcedo M
Article. 10.3389/ti.2022.10263. 2022
MRI-PDFF captures the whole spectrum of lipid composition beyond traditional histological evaluation of macrosteatosis
Marti-Aguado, David; (...); Marti-Bonmati, Luis
Meeting Abstract. 2023
Multidrug resistant bacterial infections after liver transplantation: prevalence, impact and associated risk factors
Martin-Mateos, Rosa; (...); Albillos, Agustin
Meeting Abstract. 2022
Multi-Omic Approaches to Breast Cancer Metabolic Phenotyping: Applications in Diagnosis, Prognosis, and the Development of Novel Treatments
Gomez-Cebrian, N; (...); Pineda-Lucena, A
Review. 10.3390/cancers13184544. 2021
National Survey of the SEFH-2019: portfolio of services, healthcare activity, teaching and research in Hospital Pharmacy Services in Spain (vol 45, pg 32, 2021)
Perez-Encinas, Montserrat; (...); Angel Calleja-Hernandez, Miguel
Correction. 10.7399/fh.11740. 2021
National Survey on the Use of Mobile Applications in Patients with Hemophilia and Other Coagulopathies
Eduardo Megias, Juan; (...); Poveda Andres, Jose Luis
Meeting Abstract. 10.1182/blood-2022-169938. 2022
New ERAS in liver transplantation - Past, present, and next steps
Hannon, Vivienne N.; (...); ERAS4OLT Org Working Grp
Article. 10.1111/ctr.14625. 2022
Non-alcoholic steatohepatitis as liver transplant indication: similarities and differences between a high and a low prevalence countries
Martinez-Arenas, L.; (...); Berenguer, M.
Meeting Abstract. 2022
Non-alcoholic steatohepatitis is also becoming a major liver transplant indication in Spain, a historically low risk area
Martinez-Arenas, Laura; (...); Berenguer, Marina
Meeting Abstract. 2022
Nutritional status in hepatic encephalopathy and transjugular intrahepatic portosystemic shunt-TIPS, and strategies to improve the outcomes
Review. 10.51821/86.2.11430. 2023
Obeticholic Acid and Fibrates in Primary Biliary Cholangitis: Comparative Effects in a Multicentric Observational Study.
Reig, A; (...); Pares, A
Article. 10.14309/ajg.0000000000001343. 2021
Observational study to evaluate discontinuation of monotherapy with cobicistat-boosted darunavir in patients with human immunodeficiency virus
Solana-Altabella, Antonio; (...); Poveda-Andres, Jose Luis
Article. 10.1097/MD.0000000000032208. 2022
ODs with a positive TPR conclusion, not subject to a conditional approval, and approved without requering a pass would be more likely to be reimbursed in Spain.
Poveda JL; (...); Badia X
Article. 10.1186/s13023-022-02610-4. 2023
One-quarter of chronic hepatitis D patients reach HDV-RNA decline or undetectability during the natural course of the disease
Palom, A; (...); Buti, M
Article. 10.1111/apt.16485. 2021
Open wound and cutaneous fistulization after microwave ablation of hepatocarcinoma.
Ladron Abia, Pablo; (...); Aguilera, Victoria
Article. 10.17235/reed.2022.8663/2022. 2022
Optimal management of perioperative analgesia regarding immediate and short-term outcomes after liver transplantation - A systematic review, meta-analysis and expert panel recommendations
Sun, Li-Ying; (...); ERAS4OLT Org Working Grp
Review. 10.1111/ctr.14640. 2022
OVERCOMING BARRIERS TO CARE FOR DELTA INFECTED PATIENTS
Carvalho-Gomes, Angela; (...); Berenguer, Marina
Meeting Abstract. 2022
Overcoming barriers to care for Delta infected patients
Bono, Ariadna; (...); Berenguer, Marina
Meeting Abstract. 2023
Overview of Cellular and Soluble Mediators in Systemic Inflammation Associated with Non-Alcoholic Fatty Liver Disease.
Marques, Patrice; (...); Sanz, Maria-Jesus
Article. 10.3390/ijms24032313. 2023
Pancreatic cancer, Radiomics and Artificial Intelligence: A Review.
Marti-Bonmati L; (...); Alberich-Bayarri A
Article. 10.1259/bjr.20220072. 2022
Paracetamol vs. Ibuprofen in Preterm Infants With Hemodynamically Significant Patent Ductus Arteriosus: A Non-inferiority Randomized Clinical Trial Protocol (vol 8, 372, 2020)
Garcia-Robles, Ana; (...); Aguar Carrascosa, Marta
Correction. 10.3389/fped.2021.834454. 2022
Patient and health practitioner perceptions about the role of hospital pharmacists along the care continuum: the Fharmaconectados Project
Morillo-Verdugo, R; (...); Diaz-Olmo, J
Article. 10.7399/fh.11719. 2021
Patient and health practitioner perceptions about the role of hospital pharmacists along the care continuum: the Fharmaconectados Project.
Morillo-Verdugo R; (...); Díaz-Olmo J
Article. 2021
Pharmacometabolomics by NMR in Oncology: A Systematic Review.
Gómez-Cebrián N; (...); Pineda-Lucena A
Article. 10.3390/ph14101015. 2021
Pharmacotherapeutic management of advanced therapy medicinal products
Luis Poveda-Andres, Jose; (...); Valero-Garcia, Silvia
Article. 10.7399/fh.13036. 2022
PHYSICAL FRAILTY IN LIVER TRANSPLANTATION.
Puchades Renau L; (...); Berenguer Haym M
Review. 10.17235/reed.2020.7448/2020. 2021
Porto sinusoidal vascular liver disorder: natural history and long-term outcome
Magaz, Marta; (...); Garcia Pagan, Juan Carlos
Meeting Abstract. 2023
Preparation and administration of insulin infusions in neonatology: A national survey.
Garcia-Robles, Ana; (...); Aguar Carrascosa, Marta
Article. 10.1016/j.anpede.2020.06.015. 2021
Primary biliary cholangitis and SARS-CoV-2 infection: incidence, susceptibility and outcomes.
Ampuero J; (...); Molina E
Letter. 10.1136/gutjnl-2021-325700. 2021
Primary sclerosing cholangitis as an indication for liver transplantation. Results and conditioning factors: relationship with associated intestinal pathology
Fernandez, Ainhoa; (...); Salcedo, Magdalena
Meeting Abstract. 2023
Progress and challenges of mid-infrared spectroscopy for liver characterization focusing on steatosis, fibrosis and cancer
Ten-Domenech, Isabel; (...); Quintas, Guillermo
Review. 10.1080/05704928.2023.2215858. 2024
Quantitative Prediction of Steatosis in Patients with Non-Alcoholic Fatty Liver by Means of Hepatic MicroRNAs Present in Serum and Correlating with Hepatic Fat
Quintas, Guillermo; (...); Jover, Ramiro
Article. 10.3390/ijms23169298. 2022
Recommendations for the integral diagnosis of chronic viral hepatitis in a single analytical extraction.
Crespo, Javier; (...); Calleja, Jose Luis
Practice Guideline. 10.1016/j.gastrohep.2022.09.009. 2023
Recompensation following an episode of alcohol-associated hepatitis mostly occurs in the first year of follow-up and is related to Child-Pugh score, levels of GGT and platelets, and alcohol abstinence
Gratacos, Jordi; (...); Pose, Elisa
Meeting Abstract. 2023
Re-irradiation in NSCLC High-dose RT: Control, Survival and Toxicity
Germain, J.; (...); Conde, A.
Meeting Abstract. 2023
Rising indication of non-alcoholic steatohepatitis as transplant indication in historically low risk areas
Martinez-Arenas, L.; (...); Berenguer, M.
Meeting Abstract. 2022
Risk of decompensated cirrhosis in patients with primary biliary cholangitis under first, second and third-line therapies
Lucena, Ana; (...); Ampuero, Javier
Meeting Abstract. 2023
Rivaroxaban improves survival and decompensation in cirrhotic patients with moderate liver dysfunction. Double-blind, placebocontrolled trial
Puente Sanchez, Angela; (...); Garcia Pagan, Juan Carlos
Meeting Abstract. 2023
Should we seek complete liver tests normalization in primary biliary cholangitis? Data from ColHai registry
Diaz-Gonzalez, Alvaro; (...); del Registro, Grupo
Meeting Abstract. 2022
SIMILAR POST-TRANSPLANT OUTCOMES USING DONORS AFTER CARDIAC DEATH WHEN APPLYING STRICT SELECTION CRITERIA
de la Varga, MF; (...); Aguilera, V
Meeting Abstract. 2021
Simple score to assess cardiovascular risk post-liver transplantation
Di Maira, T; (...); Berenguer, M
Meeting Abstract. 2021
SIMPLE SCORE TO ASSESS CARDIOVASCULAR RISK POST-LIVER TRANSPLANTATION
Di Maira, Tommaso; (...); Berenguer, Marina
Meeting Abstract. 2022
Sinusoidal Obstruction Syndrome after Liver Transplantation: A Multicenter Observational Study.
Caballero-Marcos A; (...); Salcedo M
Article. 10.1002/lt.26452. 2022
SMPTall man lettering application in medication information systems as a quality and safety strategy in hospital organization
Iglesias Gomez, Ruben; (...); Poveda Andres, Jose Luis
Article. 10.1111/jcpt.13703. 2022
Survey to evaluate the implementation of the recommendations on the comprehensive diagnosis of viral hepatitis in a single extraction: where are we?
Cabezas, Joaquin; (...); Crespo, Javier
Meeting Abstract. 2023
Systematic Review of Pharmacogenetics of ABC and SLC Transporter Genes in Acute Myeloid Leukemia
Megías-Vericat JE; (...); Montesinos P
Review. 10.3390/pharmaceutics14040878. 2022
The association of salivary caffeine levels with serum concentrations in premature infants with apnea of prematurity
Garcia-Robles, Ana; (...); Saenz Gonzalez, Pilar
Article. 10.1007/s00431-022-04628-z. 2022
The contribution of fenfluramine to the treatment of Dravet syndrome in Spain through Multi-Criteria Decision Analysis.
Gil-Nagel A; (...); Gil A
Article. 10.1016/j.yebeh.2022.108711. 2022
The ILTS-SETH Consensus Conference on Extrahepatic Cancer and Liver Transplantation: Paving the Way.
Colmenero J, Berenguer M, Watt KD
Article. 10.1097/TP.0000000000003994. 2022
The impact of COVID-19 on liver transplant (LT) centers across the world during the first wave: a Multisociety Survey (EASL-ESOT/ELITA-ILTS)
Russo, FP; (...); Polak, W
Meeting Abstract. 2021
The Potential Role of Efficacy and Safety Evaluation of N-Acetylcysteine Administration During Liver Procurement. The NAC-400 Single Center Randomized Controlled Trial
Gomez-Gavara, C; (...); Lopez-Andujar, R
Article. 10.1097/TP.0000000000003487. 2021
THE PRESENCE OF METABOLIC SYNDROME BEFORE TRANSPLANTATION INCREASE THE RISK OF CARDIOVASCULAR EVENTS FOLLOWING LIVER TRANSPLANTATION
Herreras, J; (...); Aguilera, V
Meeting Abstract. 2021
The Reality of Inadequate Patient Care and the Need for a Global Action Framework in Organ Donation and Transplantation.
Domínguez-Gil B; (...); Delmonico FL
Article. 10.1097/TP.0000000000004186. 2022
The role of early extubation on short-term outcomes after liver transplantation - A systematic review, meta-analysis and expert recommendations
Tinguely, Pascale; (...); ERAS4OLT Org Working Grp
Review. 10.1111/ctr.14642. 2022
The role of preoperative optimization of the nutritional status on the improvement of short-term outcomes after liver transplantation? A review of the literature and expert panel recommendations
Victor, David W.; (...); ERAS4OLT Org Working Grp
Article. 10.1111/ctr.14647. 2022
Trends in liver transplantation for acute liver failure. A Spanish multicenter study
Conde, Isabel; (...); Berenguer, Marina
Meeting Abstract. 2022
Trends in liver transplantation for acute liver failure: a Spanish multicenter study
Conde, I.; (...); Berenguer, M.
Meeting Abstract. 2022
Validation of MELD3.0 in two centres from different continents
Tejedor Bravo, Marta; (...); Berenguer, Marina
Meeting Abstract. 2023
What is the optimal management of thromboprophylaxis after liver transplantation regarding prevention of bleeding, hepatic artery, or portal vein thrombosis? A systematic review of the literature and expert panel recommendations
Kirchner, Varvara A.; (...); ERAS4OLT Org Working Grp
Review. 2022
Wilson's Disease: Facing the Challenge of Diagnosing a Rare Disease
Sánchez-Monteagudo A; (...); Espinós C
Review. 10.3390/biomedicines9091100. 2021
Worldwide variations in COVID-19 vaccination policies and practices in liver transplant settings: results of a multi-society global survey.
Di Maira, Tommaso; (...); Berenguer, Marina
Article. 10.3389/frtra.2023.1332616. 2023